foxo4-dri vs gdf-11

foxo4-dri vs gdf-11 The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound Molecular modelling of the FOXO4-TP53

Name: foxo4-dri vs gdf-11 The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound Molecular modelling of the FOXO4-TP53
Brand: mlbdaktechniek.nl
SKU: 3344849737
Price: 23.30 USD
Availability: InStock
Rating: 4.657900000000001 (20 reviews)

Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry HDAC3 represses Nrf2 GDF11 signaling to drive chondrocyte adipogenesis in temporomandibular joint osteoarthritis ScienceDirect Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age Related Cardiac Hypertrophy ScienceDirect FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness

SKU: 3344849737 · From mlbdaktechniek.nl

4.7

USD23.30 USD70.30

Pay in 4 interest-free payments of $5.83 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 8 - Aug 13

Description

A.et al (2021)

Blots were blocked with phosphate-buffered saline with 0.1% Tween 20 and then bound with antibodies for Biotin, after which an enhanced chemiluminescence (ECL) reaction was performed for blot development

Funding This study was supported by the Major Science and Technology Project of Gansu Province (Grant No

The publication reported expression of the catalytic telomerase component, detectable telomerase activity and increased mean and maximum telomere lengths